4/A

PRIMARY DOCUMENT

Company: IONIS PHARMACEUTICALS INC
Filed: February 1, 2018
Period of Report: February 1, 2018
Accession Number: 0000874015-18-000037

View Document ↗ View on SEC.gov ↗